Antibody Fc characteristics and effector functions correlate with protection from symptomatic dengue virus type 3 infection
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antibody Fc characteristics and effector functions correlate with protection from symptomatic dengue virus type 3 infection
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 14, Issue 651, Pages -
Publisher
American Association for the Advancement of Science (AAAS)
Online
2022-06-30
DOI
10.1126/scitranslmed.abm3151
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Structural basis for antibody inhibition of flavivirus NS1–triggered endothelial dysfunction
- (2021) Scott B. Biering et al. SCIENCE
- Single-cell analysis of human B cell maturation predicts how antibody class switching shapes selection dynamics
- (2021) Hamish W. King et al. Science Immunology
- Systems serology detects functionally distinct coronavirus antibody features in children and elderly
- (2021) Kevin J. Selva et al. Nature Communications
- Antibody fucosylation predicts disease severity in secondary dengue infection
- (2021) Stylianos Bournazos et al. SCIENCE
- Mapping global variation in dengue transmission intensity
- (2020) Lorenzo Cattarino et al. Science Translational Medicine
- Impact of flavivirus vaccine-induced immunity on primary Zika virus antibody response in humans
- (2020) Stefan Malafa et al. PLoS Neglected Tropical Diseases
- Maternal Anti-Dengue IgG Fucosylation Predicts Susceptibility to Dengue Disease in Infants
- (2020) Natalie K. Thulin et al. Cell Reports
- Zika virus infection enhances future risk of severe dengue disease
- (2020) Leah C. Katzelnick et al. SCIENCE
- Protective and enhancing interactions among dengue viruses 1-4 and Zika virus
- (2020) Leah C Katzelnick et al. Current Opinion in Virology
- A versatile high throughput assay to characterize antibody-mediated neutrophil phagocytosis
- (2019) Christina B. Karsten et al. JOURNAL OF IMMUNOLOGICAL METHODS
- A high-throughput, bead-based, antigen-specific assay to assess the ability of antibodies to induce complement activation
- (2019) Stephanie Fischinger et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Selective induction of antibody effector functional responses using MF59-adjuvanted vaccination
- (2019) Carolyn M. Boudreau et al. JOURNAL OF CLINICAL INVESTIGATION
- Comparison of Four Serological Methods and Two Reverse Transcription-PCR Assays for Diagnosis and Surveillance of Zika Virus Infection
- (2018) Angel Balmaseda et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Dengue Virus Induces Increased Activity of the Complement Alternative Pathway in Infected Cells
- (2018) Sheila Cabezas et al. JOURNAL OF VIROLOGY
- Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy
- (2018) Saranya Sridhar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection
- (2018) Erica Ollmann Saphire et al. CELL
- Active Human Complement Reduces the Zika Virus Load via Formation of the Membrane-Attack Complex
- (2018) Britta Schiela et al. Frontiers in Immunology
- NK cell degranulation as a marker for measuring antibody-dependent cytotoxicity in neutralizing and non-neutralizing human sera from dengue patients
- (2017) Peifang Sun et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles
- (2017) Eric P. Brown et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Neutralizing Antibody Correlates Analysis of Tetravalent Dengue Vaccine Efficacy Trials in Asia and Latin America
- (2017) Zoe Moodie et al. JOURNAL OF INFECTIOUS DISEASES
- IgG antibodies to dengue enhanced for FcγRIIIA binding determine disease severity
- (2017) Taia T. Wang et al. SCIENCE
- Antibody-dependent enhancement of severe dengue disease in humans
- (2017) Leah C. Katzelnick et al. SCIENCE
- Immune correlates of protection for dengue: State of the art and research agenda
- (2017) Leah C. Katzelnick et al. VACCINE
- CD14+CD16+ monocytes are the main target of Zika virus infection in peripheral blood mononuclear cells in a paediatric study in Nicaragua
- (2017) Daniela Michlmayr et al. Nature Microbiology
- Secreted NS1 Protects Dengue Virus from Mannose-Binding Lectin–Mediated Neutralization
- (2016) Somchai Thiemmeca et al. JOURNAL OF IMMUNOLOGY
- Neutralizing antibody titers against dengue virus correlate with protection from symptomatic infection in a longitudinal cohort
- (2016) Leah C. Katzelnick et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology
- (2015) Amy W. Chung et al. CELL
- Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America
- (2015) Luis Villar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pathologic highlights of dengue hemorrhagic fever in 13 autopsy cases from Myanmar
- (2014) Khin Saw Aye et al. HUMAN PATHOLOGY
- Human immunoglobulin classes and subclasses show variability in VDJ gene mutation levels
- (2014) Katherine J L Jackson et al. IMMUNOLOGY AND CELL BIOLOGY
- Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial
- (2014) Maria Rosario Capeding et al. LANCET
- Broadly neutralizing hemagglutinin stalk–specific antibodies require FcγR interactions for protection against influenza virus in vivo
- (2014) David J DiLillo et al. NATURE MEDICINE
- Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity
- (2013) Margaret E. Ackerman et al. JOURNAL OF CLINICAL INVESTIGATION
- Symptomatic Versus Inapparent Outcome in Repeat Dengue Virus Infections Is Influenced by the Time Interval between Infections and Study Year
- (2013) Magelda Montoya et al. PLoS Neglected Tropical Diseases
- A Temporal Model of Human IgE and IgG Antibody Function
- (2013) Andrew M. Collins et al. Frontiers in Immunology
- Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial
- (2012) Arunee Sabchareon et al. LANCET
- Role of Complement in Dengue Virus Infection: Protection or Pathogenesis?
- (2012) S. Shresta mBio
- Refining the Global Spatial Limits of Dengue Virus Transmission by Evidence-Based Consensus
- (2012) Oliver J. Brady et al. PLoS Neglected Tropical Diseases
- Development and Characterization of a Reverse Genetic System for Studying Dengue Virus Serotype 3 Strain Variation and Neutralization
- (2012) William B. Messer et al. PLoS Neglected Tropical Diseases
- Direct Complement Restriction of Flavivirus Infection Requires Glycan Recognition by Mannose-Binding Lectin
- (2010) Anja Fuchs et al. Cell Host & Microbe
- The Nicaraguan Pediatric Dengue Cohort Study: Study Design, Methods, Use of Information Technology, and Extension to Other Infectious Diseases
- (2009) G. Kuan et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Complement Protein C1q Reduces the Stoichiometric Threshold for Antibody-Mediated Neutralization of West Nile Virus
- (2009) Erin Mehlhop et al. Cell Host & Microbe
- Virus-Specific Cytolytic Antibodies to Nonstructural Protein 1 of Japanese Encephalitis Virus Effect Reduction of Virus Output from Infected Cells
- (2009) V. D. Krishna et al. JOURNAL OF VIROLOGY
- Alternative Complement Pathway Deregulation Is Correlated with Dengue Severity
- (2009) Eduardo J. M. Nascimento et al. PLoS One
- Dengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibody
- (2009) W.M.P.B. Wahala et al. VIROLOGY
- Complement and its role in protection and pathogenesis of flavivirus infections
- (2008) Panisadee Avirutnan et al. VACCINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search